Application of small molecular hyaluronic acid fragment

A technology of hyaluronic acid and human hyaluronidase, applied in the application field of small molecule hyaluronic acid fragments, can solve complex, difficult to determine clinical indications, difficult to predict small molecule hyaluronic acid clinical research and druggability. Whether it is successful or not, to achieve the effect of reducing subcutaneous fat, no allergic reaction, and suitable for mass production

Pending Publication Date: 2018-11-02
惠觅宙
View PDF11 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the recent patent WO/2014/165713 of CEDARS-SINAI MEDICAL CENTER shows that the small molecule hyaluronic acid produced by bacterial streptococci hyaluronidase cutting less than 10KD does not cause inflammation, but the bacterial Streptomyces hyaluronidase produces more than 10KD However, the small molecule hyaluronic acid caused inflammation, suggesting that the function of the small molecule hyaluronic acid may also be related to the type of cutting enzyme (that is, related to the three-dimensional structure or molecular arrangement of the cleaved hyaluronic acid fragments)
[0022] The above contradictory research results suggest that the exact function of small-molecule hyaluronic acid fragments is currently difficult to determine. Perhaps the production method, molecular weight, type of cutting enzyme, and method of use of small-molecule hyaluronic acid fragments may affect their functional perf

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of small molecular hyaluronic acid fragment
  • Application of small molecular hyaluronic acid fragment
  • Application of small molecular hyaluronic acid fragment

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0078] Objective: Production of recombinant human hyaluronidase PH20 and preparation of injection containing small molecule hyaluronic acid fragments

[0079] Method: Based on the methods recorded in patent documents of CN104342420A, CN103468662A and CN105018547A, animal cells (CHO cells) were used to produce glycosylated recombinant human hyaluronidase PH20. Including: artificially synthesizing the gene cDNA of recombinant human hyaluronidase PH20 with glycosylation, inserting GC-rich pMH3, pMH4, pMH5 empty expression vectors, and constructing pMH3-PH20, pMH4-PH20, pMH5-PH20 expression vectors (adopted by the announcement No. CN102124019A patent literature record method to construct expression vector so as to express recombinant protein very high); then the cDNA expression vector of pMH3-PH20, pMH4-PH20, pMH5-PH20 is transferred into CHO-S cell line, and the high expression PH20 of screening CHO-S cell line, in figure 1 The torrent-type animal cell reactor shown is used for ...

Embodiment 2

[0090] Objective: To study the in vitro experiment, molecular cytology experiment and small animal experiment of the above-mentioned hyaluronic acid fragment injection (injection 1 and injection 2).

[0091] Methods: Injection 1 and Injection 2 diluted 1-fold with normal saline were used for in vitro antibacterial experiments, molecular cytology experiments, and small animal antibacterial experiments, respectively.

[0092] result: Figure 4 It shows that Injection 1 inhibits the growth of Porphyromonas gingivalis clones in vitro experiments, suggesting that hyaluronic acid fragment injection is not conducive to the growth of Porphyromonas gingivalis (Note: The negative control is normal saline, and the positive control is the antibiotic metronidazole) ;

[0093] Figure 5 It shows that injection 1 inhibits the growth of Pyophyllomonas gingivalis clones in mice, suggesting that hyaluronic acid fragment injection is not conducive to the growth of Pyophyllomonas gingivalis in ...

Embodiment 3

[0100] Research background: The research in Example 2 shows that B-HA may achieve anti-inflammation, pain relief, antipruritic and effective treatment of various diseases and diseases through a new mechanism that binds to TLR4 and promotes the secretion of anti-inflammatory cytokine IL-10 status role. This novel mechanism provides a rationale for B-HA's unexpected ability to treat a variety of diseases and disease states.

[0101] Objective: To study the inflammatory effect of the above-mentioned hyaluronic acid fragment injection (injection 1 and injection 2) on small animals and on large animals.

[0102] Research background: Literature research shows that the biological activity of hyaluronic acid is not only related to molecular weight and / or preparation method, but also related to animal size. Studies on small animals and mice suggest that the biological activity of hyaluronic acid is to promote inflammation, but experimental studies on large animals and humans have show...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Based on the clinical experimental study of a small molecular hyaluronic acid fragment in small animals, large animals and human body, a series of novel uses of the hyaluronic acid fragment for injection are discovered. The experimental results show that the small molecular hyaluronic acid fragment has an unexpected therapeutic effect on various diseases when injected, and has the effects of rapidly relieving pain, relieving itching and increasing physical and mental strength, thereby making the small molecular hyaluronic acid fragment have great application value in the preparation of treatment or adjuvant treatment drugs for related diseases. In addition, the experimental results also show that the small molecular hyaluronic acid fragment can reduce subcutaneous fat, especially in the head, face and neck of the human body. Meanwhile, the small molecular hyaluronic acid fragment also has the effects of facial beauty and anti-aging, and can be injected through an abdominal subcutaneousfat layer when used without facial injection, and causes no pain and facial inflammation. Thus, the small molecular hyaluronic acid fragment also has a prominent application potential in the field ofbody shaping and cosmetology.

Description

technical field [0001] The present invention relates to the field of application of small molecular hyaluronic acid fragments, in particular to the application of small molecular hyaluronic acid fragments in the preparation of medicines for treating various diseases including solid tumors, as well as in facial beauty, increasing physical strength and energy, Uses such as reducing subcutaneous fat. Background technique [0002] Hyaluronic acid, also known as hyaluronic acid, uronic acid, hyaluronic acid, English name hyaluronic acid (referred to as HA), is a high-level polysaccharide composed of D-glucuronic acid and N-acetylglucosamine, and the number of disaccharide units can reach 25,000 you. Tissues such as human subcutaneous tissue, epidermis and oropharyngeal mucosa contain a large amount of macromolecular hyaluronic acid. In other words, macromolecular hyaluronic acid is the basic building material of various tissues such as human skin, mucous membranes, and subcutan...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/728A61P35/00A61P27/02A61P27/04A61P21/00A61P19/08A61P19/06A61P19/02A61P9/00A61P9/10A61P15/00A61P1/02A61P11/00A61P17/00A61P17/06A61P17/02A61P17/04A61P1/18A61P17/18A61P3/04C12P19/26C12P19/14
CPCA61K31/728C12P19/14C12P19/26
Inventor 惠觅宙
Owner 惠觅宙
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products